| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Prepaid expenses and other current assets | 3,371 | |||
| Marketable securities | 37,352 | |||
| Cash and cash equivalents | 58,290 | |||
| Total current assets | 99,013 | |||
| Property and equipment, net | 419 | |||
| Right-of-use asset | 2,561 | |||
| Deposits and other assets | 24,173 | |||
| Total assets | 126,166 | |||
| Accrued expenses and other current liabilities | 2,978 | |||
| Operating lease liability | 3,834 | |||
| Accounts payable | 512 | |||
| Total current liabilities | 7,324 | |||
| Other long-term liabilities | 1,092 | |||
| Long-term portion of operating lease liability | 1,843 | |||
| Total liabilities | 10,259 | |||
| Accumulated deficit | -343,005 | |||
| Common stock, 0.001 par value, 150,000,000 shares authorized and 48,258,111 shares issued and outstanding as of june 30, 2025 and december 31, 2024 | 48 | |||
| Additional paid-in capital | 458,799 | |||
| Accumulated other comprehensive income | 65 | |||
| Total stockholders' equity | 115,907 | |||
| Total liabilities and stockholders' equity | 126,166 | |||
Ikena Oncology, Inc. (IKNA)
Ikena Oncology, Inc. (IKNA)